JCI - Citations to Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.

Citations to this article

Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.

D A Arenberg, … , M D Iannettoni, R M Strieter

D A Arenberg, … , M D Iannettoni, R M Strieter

Published August 1, 1998
Citation Information: J Clin Invest. 1998;102(3):465-472. https://doi.org/10.1172/JCI3145.

View: Text | PDF

Research Article

Total citations by year

Year:	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1994	1985	Total
Citations:	2	2	1	5	10	7	3	5	3	5	11	10	8	8	10	13	10	13	10	12	13	11	9	5	7	3	7	1	2	206

Citation information

Citations to this article (206)

Title and authors	Publication	Year
The role of CXC chemokines and receptors in breast cancer Masrour M, Moeinafshar A, Poopak A, Razi S, Rezaei N	Clinical and Experimental Medicine	2025
Targeting neutrophils for cancer therapy. Kwak JW, Houghton AM	Nature reviews. Drug discovery	2025
Emerging immunologic approaches as cancer anti-angiogenic therapies. Azimi M, Manavi MS, Afshinpour M, Khorram R, Vafadar R, Rezaei-Tazangi F, Arabzadeh D, Arabzadeh S, Ebrahimi N, Aref AR	Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico	2024
The role of periodontitis in cancer development, with a focus on oral cancers. Farhad SZ, Karbalaeihasanesfahani A, Dadgar E, Nasiri K, Esfahaniani M, Nabi Afjadi M	Molecular biology reports	2024
Add fuel to the fire: Inflammation and immune response in lung cancer combined with COVID-19. Ai Y, Wang H, Zheng Q, Li S, Liu J, Huang J, Tang J, Meng X	Frontiers in immunology	2023
Epigenetic alterations of CXCL5 in Cr(VI)-induced carcinogenesis Ge X, He J, Wang L, Zhao L, Wang Y, Wu G, Liu W, Shu Y, Gong W, Ma XL, Wang Y, Jiang BH, Liu LZ	The Science of The Total Environment	2022
CXCL5: A coachman to drive cancer progression Deng J, Jiang R, Meng E, Wu H	Frontiers in Oncology	2022
Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations. Balázs K, Kocsis ZS, Ágoston P, Jorgo K, Gesztesi L, Farkas G, Székely G, Takácsi-Nagy Z, Polgár C, Sáfrány G, Jurányi Z, Lumniczky K	Cancers	2022
Regenerative Potential of A Bovine ECM-Derived Hydrogel for Biomedical Applications. Di Francesco D, Bertani F, Fusaro L, Clemente N, Carton F, Talmon M, Fresu LG, Boccafoschi F	Biomolecules	2022
The Role of CXC Chemokines in Cancer Progression. Wu T, Yang W, Sun A, Wei Z, Lin Q	Cancers	2022
The Role of Post-Translational Modifications of Chemokines by CD26 in Cancer AD Zutter, JV Damme, S Struyf	Cancers	2021
Immunological comparison of pregnant Dahl salt-sensitive and Sprague-Dawley rats commonly used to model characteristics of preeclampsia EB Taylor, EM George, MJ Ryan, MR Garrett, JM Sasser	American Journal of Physiology - Regulatory, Integrative and Comparative Physiology	2021
Classical and Non-classical Fibrosis Phenotypes Are Revealed by Lung and Cardiac Like Microvascular Tissues On-Chip A Akinbote, V Beltran-Sastre, M Cherubini, R Visone, C Hajal, D Cobanoglu, K Haase	Frontiers in physiology	2021
Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth E Reijmen, SD Mey, HV Damme, KD Ridder, T Gevaert, ED Blay, L Bouwens, C Collen, L Decoster, MD Couck, D Laoui, JD Grève, MD Ridder, Y Gidron, C Goyvaerts	Frontiers in immunology	2021
Prophylactic role of Korean Red Ginseng in astrocytic mitochondrial biogenesis through HIF-1α. Park J, Lee M, Kim M, Moon S, Kim S, Kim S, Koh SH, Kim YM, Choi YK	Journal of Ginseng Research	2021
Role of Cytokines and Chemokines in NSCLC Immune Navigation and Proliferation S Ramachandran, AK Verma, K Dev, Y Goyal, D Bhatt, MA Alsahli, AH Rahmani, A Almatroudi, SA Almatroodi, F Alrumaihi, NA Khan, J Ghose	Oxidative Medicine & Cellular Longevity	2021
CXCL5/NF-κB Pathway as a Therapeutic Target in Hepatocellular Carcinoma Treatment X Jia, S Wei, W Xiong, MW Khan	Journal of Oncology	2021
Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools N Unver	Medical Oncology	2021
Pluripotent stem cell-derived mesenchymal stromal cells improve cardiac function and vascularity after myocardial infarction S Thavapalachandran, TY Le, S Romanazzo, FN Rashid, M Ogawa, KA Kilian, P Brown, J Pouliopoulos, AM Barry, P Fahmy, K Kelly, E Kizana, JJ Chong	Cytotherapy	2021
Prophylactic role of Korean red ginseng in astrocytic mitochondrial biogenesis through HIF-1α J Park, M Lee, M Kim, S Moon, S Kim, S Kim, SH Koh, YM Kim, YK Choi	Journal of Ginseng Research	2021
The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment A Bikfalvi, C Billottet	American journal of physiology. Cell physiology	2020
Cytotoxic and anti-angiogenic effects of zoledronic acid in DU-145 and PC-3 prostate cancer cell lines C Gokalp	Molecular Biology Reports	2020
miR-588 is a prognostic marker in gastric cancer Y Chen, J Zhang, W Gong, W Dai, X Xu, S Xu	Aging	2020
The use of tissue‐engineered skin to demonstrate the negative effect of CXCL5 on epidermal ultraviolet radiation‐induced cyclobutane pyrimidine dimer repair efficiency MM Dorr, R Guignard, FA Auger, PJ Rochette	British Journal of Dermatology	2020
C-C Motif Chemokine 8 promotes angiogenesis in vascular endothelial cells S Xue, H Tang, G Zhao, Y Shen, EY Yang, W Fu, Z Shi, X Tang, D Guo	Vascular	2020
CXCL5‐CXCR2 signaling is a senescence‐associated secretory phenotype in preimplantation embryos Y Kawagoe, I Kawashima, Y Sato, N Okamoto, K Matsubara, K Kawamura	Aging Cell	2020
Periodontitis and oral cancer - current concepts of the etiopathogenesis S Irani, I Barati, M Badiei	Oncology Reviews	2020
CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer C Chen, ZQ Xu, YP Zong, BC Ou, XH Shen, H Feng, MH Zheng, JK Zhao, AG Lu	Cell Death and Disease	2019
Potential Roles and Targeted Therapy of the CXCLs/CXCR2 Axis in Cancer and Inflammatory Diseases Y Cheng, X Ma, Y Wei, XW Wei	Biochimica et Biophysica Acta (BBA) - Reviews on Cancer	2019
Transcriptomic Profiling of Adipose Derived Stem Cells Undergoing Osteogenesis by RNA-Seq S Shaik, EC Martin, DJ Hayes, JM Gimble, RV Devireddy	Scientific Reports	2019
CXCL5 promotes mitomycin C resistance in non-muscle invasive bladder cancer by activating EMT and NF-κB pathway C Wang, A Li, S Yang, R Qiao, , J Zhang	Biochemical and Biophysical Research Communications	2018
Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis B Hu, H Fan, X Lv, S Chen, Z Shao	Cancer Cell International	2018
CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells L Wang, L Shi, J Gu, C Zhan, , J Ding, D Ge	Journal of Physiology and Biochemistry	2018
CXCL5 Facilitates Melanoma Cell–Neutrophil Interaction and Lymph Node Metastasis A Soler-Cardona, A Forsthuber, K Lipp, S Ebersberger, M Heinz, K Schossleitner, E Buchberger, M Gröger, P Petzelbauer, C Hoeller, E Wagner, R Loewe	Journal of Investigative Dermatology	2018
Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma CS Huang, SJ Tang, MH Lee, CC Wang, GH Sun, KH Sun	Journal of Cellular and Molecular Medicine	2018
Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea P Mirabelli, A Mukwaya, A Lennikov, M Xeroudaki, B Peebo, M Schaupper, N Lagali	Scientific Reports	2017
The clinical significance of CXCL5 in non-small cell lung cancer K Wu, S Yu, Q Liu, X Bai, X Zheng, K Wu	OncoTargets and therapy	2017
CXCL5 as an autocrine or paracrine cytokine is associated with proliferation and migration of hepatoblastoma HepG2 cells Y Yang, J Hou, M Shao, W Zhang, Y Qi, S E, S Wang, H Sui, D Meng, B Wang, M Wang, Y Han, Y Cao, X Huang, Y Li, P Zhang, W Wang	Oncology Letters	2017
Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor Microenvironment R Chan, P Sethi, A Jyoti, R McGarry, M Upreti	Radiation Research	2016
Chemokines and their receptors in lung cancer progression and metastasis Z CHENG	Journal of Zhejiang University SCIENCE B	2016
Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies SH Choi, D Ruggiero, R Sorice, C Song, T Nutile, AV Smith, MP Concas, M Traglia, C Barbieri, NC Ndiaye, MG Stathopoulou, V Lagou, GB Maestrale, C Sala, S Debette, P Kovacs, L Lind, J Lamont, P Fitzgerald, A Tönjes, V Gudnason, D Toniolo, M Pirastu, C Bellenguez, RS Vasan, E Ingelsson, AL Leutenegger, AD Johnson, AL DeStefano, S Visvikis-Siest, S Seshadri, M Ciullo, E Zeggini	PLoS genetics	2016
INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer S Zhang, B Zhou, L Wang, P Li, BD Bennett, R Snyder, S Garantziotis, DC Fargo, AD Cox, L Chen, G Hu	Oncogene	2016
Neutrophil to Lymphocyte Ratio (NLR) and Derived Neutrophil to Lymphocyte Ratio (d-NLR) Predict Non-Responders and Postoperative Complications in Patients Undergoing Radical Surgery After Neo-Adjuvant Radio-Chemotherapy for Rectal Adenocarcinoma D Caputo, M Caricato, A Coppola, VL Vaccara, M Fiore, R Coppola	Cancer Investigation	2016
Chemokine Function in Periodontal Disease and Oral Cavity Cancer SE Sahingur, WA Yeudall	Frontiers in immunology	2015
HOXC10 up-regulation contributes to human thyroid cancer and indicates poor survival outcome X Feng, T Li, Z Liu, Y Shi, Y Peng	Molecular BioSystems	2015
Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer JB Lim, HW Chung	Cytokine	2015
In vitro and in vivo anti-angiogenic activity of girinimbine isolated from Murraya koenigii SM Noor, V Iman, M Syam, MI Noordin, MR Mustafa, Y Hobani, H Karimian	Drug design, development and therapy	2015
Association between preeclampsia and the CXC chemokine family (Review) X Liu, L Dai, R Zhou	Experimental and therapeutic medicine	2015
Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents J Valdivia-Silva, J Medina-Tamayo, E Garcia-Zepeda	International journal of molecular sciences	2015
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation Selma Rivas-Fuentes, Alfonso Salgado-Aguayo, Silvana Pertuz Belloso, Patricia Gorocica Rosete, Noé Alvarado-Vásquez, Guillermo Aquino-Jarquin	Journal of Cancer	2015
Chemokine Expression Profiles of Human Hepatoma Cell Lines Mediated by Hepatitis B Virus X Protein DY Wang, LP Zou, XJ Liu, HG Zhu, R Zhu	Pathology & Oncology Research	2015
Small cell lung cancer: Recruitment of macrophages by circulating tumor cells G Hamilton, B Rath, L Klameth, MJ Hochmair	OncoImmunology	2015
Contact-dependent carcinoma aggregate dispersion by M2a macrophages via ICAM-1 and β2 integrin interactions J Bai, G Adriani, TM Dang, TY Tu, HX Penny, SC Wong, RD Kamm, JP Thiery	Oncotarget	2015
MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation Fengjie Guo, Lili Guo, Yongwen Li, Qinghua Zhou, Zhigang Li	International journal of clinical and experimental pathology	2015
The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling C Stockmann, D Schadendorf, R Klose, I Helfrich	Frontiers in Oncology	2014
Comprehensive Physiology SN Cheuvront, RW Kenefick	Comprehensive Physiology	2014
CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes O Kowalczuk, T Burzykowski, WE Niklinska, M Kozlowski, L Chyczewski, J Niklinski	Tumor Biology	2014
Fibroblast α11β1 integrin regulates tensional homeostasis in fibroblast/A549 carcinoma heterospheroids N Lu, TV Karlsen, RK Reed, M Kusche-Gullberg, D Gullberg	PloS one	2014
CXCL5 knockdown expression inhibits human bladder cancer T24 cells proliferation and migration J Zheng, X Zhu, J Zhang	Biochemical and Biophysical Research Communications	2014
Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes CJ Rossant, D Carroll, L Huang, J Elvin, F Neal, E Walker, JJ Benschop, EE Kim, ST Barry, TJ Vaughan	mAbs	2014
A dual role for autophagy in a murine model of lung cancer S Rao, L Tortola, T Perlot, G Wirnsberger, M Novatchkova, R Nitsch, P Sykacek, L Frank, D Schramek, V Komnenovic, V Sigl, K Aumayr, G Schmauss, N Fellner, S Handschuh, M Glösmann, P Pasierbek, M Schlederer, GP Resch, Y Ma, H Yang, H Popper, L Kenner, G Kroemer, JM Penninger	Nature Communications	2014
Ratios derived from an array of standard haematological indices predict the oncological outcome in colon cancer JM East, J Hogan, G Samaha, M Medani, W MacKerricher, S Polinkevych, SR Walsh, JC Coffey	Colorectal Disease	2014
CXCL5 abundant in the wound fluid at the late phase of wound healing, possibly promoting migration of mesenchymal stem cells and vascular tube formation E Chung, W Ahn, Y Son	Tissue Engineering and Regenerative Medicine	2014
Fibroblast α11β1 Integrin Regulates Tensional Homeostasis in Fibroblast/A549 Carcinoma Heterospheroids N Lu, TV Karlsen, RK Reed, M Kusche-Gullberg, D Gullberg, NK Karamanos	PloS one	2014
CXCR2: a target for pancreatic cancer treatment? KM Hertzer, GW Donald, OJ Hines	Expert Opinion on Therapeutic Targets	2013
One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment X Yang, J Hou, Z Han, Y Wang, C Hao, L Wei, Y Shi	Cell & Bioscience	2013
IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer P Kachroo, MH Lee, L Zhang, F Baratelli, G Lee, MK Srivastava, G Wang, TC Walser, K Krysan, S Sharma, SM Dubinett, JM Lee	Journal of Experimental & Clinical Cancer Research	2013
Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: A case control study A Rafrafi, B Chahed, S Kaabachi, W Kaabachi, H Maalmi, K Hamzaoui, FH Sassi	Human Immunology	2013
Exploring the role of CHI3L1 in "pre-metastatic" lungs of mammary tumor-bearing mice S Libreros, R Garcia-Areas, P Keating, R Carrio, VL Iragavarapu-Charyulu	Frontiers in physiology	2013
Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis JY Hsieh, HW Wang, SJ Chang, KH Liao, IH Lee, WS Lin, CH Wu, WY Lin, SM Cheng	PloS one	2013
Vascular Endothelial Growth Factor Induces CXCL1 Chemokine Release via JNK and PI-3K-Dependent Pathways in Human Lung Carcinoma Epithelial Cells HM Lo, JM Shieh, CL Chen, CJ Tsou, WB Wu	International journal of molecular sciences	2013
Mesenchymal Stem Cells from Human Umbilical Cord Express Preferentially Secreted Factors Related to Neuroprotection, Neurogenesis, and Angiogenesis JY Hsieh, HW Wang, SJ Chang, KH Liao, IH Lee, WS Lin, CH Wu, WY Lin, SM Cheng, XM Shi	PloS one	2013
Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression MA López-Lago, S Posner, VJ Thodima, AM Molina, RJ Motzer, RS Chaganti	Oncogene	2012
Ovarian cancer stroma: pathophysiology and the roles in cancer development M Furuya	Cancers	2012
Mass Homozygotes Accumulation in the NCI-60 Cancer Cell Lines As Compared to HapMap Trios, and Relation to Fragile Site Location X Ruan, JP Kocher, Y Pommier, H Liu, WC Reinhold	PloS one	2012
Development of novel CXCR4-based therapeutics A Peled, O Wald, J Burger	Expert Opinion on Investigational Drugs	2012
Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts H Okabe, T Beppu, M Ueda, H Hayashi, T Ishiko, T Masuda, R Otao, H Horlad, K Mima, K Miyake, M Iwatsuki, Y Baba, H Takamori, H Jono, S Shinriki, Y Ando, H Baba	International Journal of Cancer	2012
Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma SL Zhou, Z Dai, ZJ Zhou, XY Wang, GH Yang, Z Wang, XW Huang, J Fan, J Zhou	Hepatology	2012
Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor HC Chiang, YS Wang, CH Chou, AT Liao, RM Chu, CS Lin	BMC veterinary research	2012
Mass Homozygotes Accumulation in the NCI-60 Cancer Cell Lines As Compared to HapMap Trios, and Relation to Fragile Site Location X Ruan, JP Kocher, Y Pommier, H Liu, WC Reinhold, P Tan	PloS one	2012
The role of chemokines and their receptors in angiogenesis F Kiefer, AF Siekmann	Cellular and Molecular Life Sciences	2011
CXCL5 plasma levels are decreased in patients with chronic liver disease F Tacke, HW Zimmermann, C Trautwein, B Schnabl	Journal of Gastroenterology and Hepatology	2011
Targeting of the innate immunity/inflammation as complementary anti-tumor therapies G Germano, A Mantovani, P Allavena	Annals of Medicine	2011
Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis M Furuya, T Yoneyama, E Miyagi, R Tanaka, K Nagahama, Y Miyagi, Y Nagashima, F Hirahara, Y Inayama, I Aoki	Gynecologic Oncology	2011
Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth S Tazzyman, ST Barry, S Ashton, P Wood, D Blakey, CE Lewis, C Murdoch	International Journal of Cancer	2011
Advances in Cancer Research M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken	Advances in Cancer Research Volume 110	2011
Overexpression of CXCL5 Is Associated With Poor Survival in Patients With Pancreatic Cancer A Li, J King, A Moro, MD Sugi, DW Dawson, J Kaplan, G Li, X Lu, RM Strieter, M Burdick, VL Go, HA Reber, G Eibl, OJ Hines	The American Journal of Pathology	2011
Gene expression profiling of the androgen independent prostate cancer cells demonstrates complex mechanisms mediating resistance to docetaxel F Desarnaud, P Geck, C Parkin, G Carpinito, AN Makarovskiy	Cancer biology & therapy	2011
CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer M Kawamura, Y Toiyama, K Tanaka, S Saigusa, Y Okugawa, J Hiro, K Uchida, Y Mohri, Y Inoue, M Kusunoki	European Journal of Cancer	2011
Novel Developments in Stem Cell Mobilization S Fruehauf, WJ Zeller, G Calandra		2011
CXC chemokines in cancer angiogenesis and metastases EC Keeley, B Mehrad, RM Strieter	Advances in cancer research	2010
Macrophage Migration Inhibitory Factor Promotes Tumor Growth in the Context of Lung Injury and Repair D Arenberg, TR Luckhardt, S Carskadon, L Zhao, MA Amin, AE Koch	American journal of respiratory and critical care medicine	2010
Differential activity of pro-angiogenic CXC chemokines A Moldobaeva, A Baek, L Eldridge, EM Wagner	Microvascular Research	2010
Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate U Joimel, C Gest, J Soria, LL Pritchard, J Alexandre, M Laurent, E Blot, L Cazin, JP Vannier, R Varin, H Li, C Soria	BMC Cancer	2010
Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis M Tessema, DM Klinge, CM Yingling, K Do, LV Neste, SA Belinsky	Oncogene	2010
Chemokines and hepatocellular carcinoma F Huang, XP Geng	World journal of gastroenterology : WJG	2010
Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic properties H Zhang, H Ning, L Banie, G Wang, G Lin, TF Lue, CS Lin	Biochemical and Biophysical Research Communications	2010
3,3′-diindolylmethane suppresses 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and tumor promotion in mouse skin via the downregulation of inflammatory mediators EJ Kim, H Park, J Kim, JH Park	Molecular Carcinogenesis	2010
Canine CXCL7 and its functional expression in dendritic cells undergoing maturation YS Wang, KW Liao, MF Chen, YC Huang, RM Chu, KH Chi	Veterinary Immunology and Immunopathology	2010
Current Topics in Membranes TC Wagenknecht, Z Liu	Structure and Function of Calcium Release Channels	2010
New biomarkers for lung cancer M Paci, C Rapicetta, S Maramotti	Expert Opinion on Medical Diagnostics	2010
Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo SH Jafri, J Glass, R Shi, S Zhang, M Prince, H Kleiner-Hancock	Journal of Experimental & Clinical Cancer Research	2010
The Tumor Microenvironment RG Bagley	The Tumor Microenvironment	2010
CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance C Chavey, G Lazennec, S Lagarrigue, C Clapé, I Iankova, J Teyssier, JS Annicotte, J Schmidt, C Mataki, H Yamamoto, R Sanches, A Guma, V Stich, M Vitkova, B Jardin-Watelet, E Renard, R Strieter, A Tuthill, GS Hotamisligil, A Vidal-Puig, A Zorzano, D Langin, L Fajas	Cell Metabolism	2009
Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection J Yee, MD Sadar, DD Sin, M Kuzyk, L Xing, J Kondra, A McWilliams, SF Man, S Lam	Journal of Clinical Oncology	2009
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer Y Matsuo, M Raimondo, TA Woodward, MB Wallace, KR Gill, Z Tong, MD Burdick, Z Yang, RM Strieter, RM Hoffman, S Guha	International Journal of Cancer	2009
The role of angiogenesis in solid tumours: An overview N Makrilia, T Lappa, V Xyla, I Nikolaidis, K Syrigos	European Journal of Internal Medicine	2009
The role of chemokines in cancer immune surveillance by the adaptive immune system C Krieg, O Boyman	Seminars in Cancer Biology	2009
Connective Tissue-Activating Peptide III: A Novel Blood Biomarker for Early Lung Cancer Detection J Yee, MD Sadar, DD Sin, M Kuzyk, L Xing, J Kondra, A McWilliams, SF Man, S Lam	Journal of Clinical Oncology	2009
Principles of Cancer Biotherapy RK Oldham, RO Dillman		2009
Lung Cancer Metastasis V Keshamouni, D Arenberg, G Kalemkerian		2009
Chemokine Receptors in Cancer AM Fulton		2009
Snail Promotes CXCR2 Ligand–Dependent Tumor Progression in Non–Small Cell Lung Carcinoma J Yanagawa, TC Walser, LX Zhu, L Hong, MC Fishbein, V Mah, D Chia, L Goodglick, DA Elashoff, J Luo, CE Magyar, M Dohadwala, JM Lee, MA John, RM Strieter, S Sharma, SM Dubinett	Clinical cancer research	2009
The role of CXC chemokines and their receptors in cancer J Vandercappellen, JV Damme, S Struyf	Cancer Letters	2008
Chemokines as Mediators of Neovascularization EC Keeley, B Mehrad, RM Strieter	Arteriosclerosis, thrombosis, and vascular biology	2008
The role of myeloid cells in the promotion of tumour angiogenesis C Murdoch, M Muthana, SB Coffelt, CE Lewis	Nature Reviews Cancer	2008
Cyclic AMP-Responsive Element Binding Protein– and Nuclear Factor-κB–Regulated CXC Chemokine Gene Expression in Lung Carcinogenesis H Sun, WC Chung, SH Ryu, Z Ju, HT Tran, E Kim, JM Kurie, JS Koo	Cancer prevention research (Philadelphia, Pa.)	2008
Pten Inactivation Accelerates Oncogenic K-ras –Initiated Tumorigenesis in a Mouse Model of Lung Cancer K Iwanaga, Y Yang, MG Raso, L Ma, AE Hanna, N Thilaganathan, S Moghaddam, CM Evans, H Li, WW Cai, M Sato, JD Minna, H Wu, CJ Creighton, FJ Demayo, II Wistuba, JM Kurie	Cancer research	2008
Identification of Secreted Proteins that Mediate Cell-Cell Interactions in an In vitro Model of the Lung Cancer Microenvironment L Zhong, J Roybal, R Chaerkady, W Zhang, K Choi, CA Alvarez, H Tran, CJ Creighton, S Yan, RM Strieter, A Pandey, JM Kurie	Cancer research	2008
CXCR2 and RET Single Nucleotide Polymorphisms in Pancreatic Cancer TR Donahue, OJ Hines	World Journal of Surgery	2008
ELR+ CXC chemokine expression in benign and malignant colorectal conditions C Rubie, VO Frick, M Wagner, J Schuld, S Gräber, B Brittner, RM Bohle, MK Schilling	BMC Cancer	2008
Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation K Fujita, CM Ewing, LJ Sokoll, DJ Elliott, M Cunningham, AM de Marzo, WB Isaacs, CP Pavlovich	The Prostate	2008
Differential CXC Receptor Expression in Colorectal Carcinomas C Rubie, O Kollmar, VO Frick, M Wagner, B Brittner, S Gräber, MK Schilling	Scandinavian Journal of Immunology	2008
Molecular Pathology of Lung Diseases DS Zander, HH Popper, J Jagirdar, AK Haque, PT Cagle, R Barrios		2008
Cooperative Regulation of Non-Small Cell Lung Carcinoma Angiogenic Potential by Macrophage Migration Inhibitory Factor and Its Homolog, d-Dopachrome Tautomerase AM Coleman, BE Rendon, M Zhao, MW Qian, R Bucala, D Xin, RA Mitchell	Journal of immunology (Baltimore, Md. : 1950)	2008
G-protein coupled chemoattractant receptors and cancer J Huang	Frontiers in bioscience : a journal and virtual library	2008
Enhanced CXCL1 production and angiogenesis in adenosine-mediated lung disease A Mohsenin, MD Burdick, JG Molina, MP Keane, MR Blackburn	The FASEB Journal	2007
Chemokines in tumor angiogenesis and metastasis S Singh, A Sadanandam, RK Singh	Cancer and Metastasis Reviews	2007
Clinical utilization of chemokines to combat cancer: the double-edged sword C Dell'Agnola, A Biragyn	Expert Review of Vaccines	2007
CXCL5 overexpression is associated with late stage gastric cancer JY Park, KH Park, S Bang, MH Kim, JE Lee, J Gang, SS Koh, SY Song	Journal of Cancer Research and Clinical Oncology	2007
Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis M Furuya, T Suyama, H Usui, Y Kasuya, M Nishiyama, N Tanaka, I Ishiwata, Y Nagai, M Shozu, S Kimura	Human Pathology	2007
Chemokines as mediators of angiogenesis B Mehrad, MP Keane, RM Strieter	Thrombosis and Haemostasis	2007
Lung Cancer Chemoprevention J Gray, JT Mao, E Szabo, M Kelley, J Kurie, G Bepler	Chest	2007
The role of CXCR 2 in systemic neovascularization of the mouse lung J Sánchez, A Moldobaeva, J McClintock, J Jenkins, E Wagner	Journal of applied physiology	2007
The Chemokine Receptors JK Harrison, NW Lukacs		2007
Cytokines in the Genesis and Treatment of Cancer MA Caligiuri, MT Lotze		2007
Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis J Pan, J Mestas, MD Burdick, RJ Phillips, GV Thomas, K Reckamp, JA Belperio, RM Strieter	Molecular Cancer	2006
Cancer CXC chemokine networks and tumour angiogenesis RM Strieter, MD Burdick, J Mestas, B Gomperts, MP Keane, JA Belperio	European Journal of Cancer	2006
CXCR3/CXCR3 Ligand Biological Axis Impairs RENCA Tumor Growth by a Mechanism of Immunoangiostasis J Pan, MD Burdick, JA Belperio, YY Xue, C Gerard, S Sharma, SM Dubinett, RM Strieter	Journal of immunology (Baltimore, Md. : 1950)	2006
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis MN Wente, MP Keane, MD Burdick, H Friess, MW Büchler, GO Ceyhan, HA Reber, RM Strieter, OJ Hines	Cancer Letters	2006
ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets C Bizzarri, AR Beccari, R Bertini, MR Cavicchia, S Giorgini, M Allegretti	Pharmacology & Therapeutics	2006
Chemokines in the Biology of Lung Cancer D Arenberg	Journal of Thoracic Oncology	2006
The chemokine network: A target in cancer biology? VI Slettenaar, JL Wilson	Advanced Drug Delivery Reviews	2006
Chemokines in Lung Cancer BN Gomperts, RM Strieter	Clinical Pulmonary Medicine	2006
Diversity of the angiogenic phenotype in non-small cell lung cancer MR McClelland, SL Carskadon, L Zhao, ES White, DG Beer, MB Orringer, A Pickens, AC Chang, DA Arenberg	American journal of respiratory cell and molecular biology	2006
VCC-1, a novel chemokine, promotes tumor growth EJ Weinstein, R Head, DW Griggs, D Sun, RJ Evans, ML Swearingen, MM Westlin, R Mazzarella	Biochemical and Biophysical Research Communications	2006
Pulmonary ischemia induces lung remodeling and angiogenesis EM Wagner, I Petrache, B Schofield, W Mitzner	Journal of applied physiology	2006
CD4 + CXCR4 high CD69 + T Cells Accumulate in Lung Adenocarcinoma O Wald, U Izhar, G Amir, S Avniel, Y Bar-Shavit, H Wald, ID Weiss, E Galun, A Peled	Journal of immunology (Baltimore, Md. : 1950)	2006
Difference in proangiogenic potential of systemic and pulmonary endothelium: role of CXCR2 A Moldobaeva, EM Wagner	American journal of physiology. Lung cellular and molecular physiology	2005
IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis M Numasaki, M Watanabe, T Suzuki, H Takahashi, A Nakamura, F McAllister, T Hishinuma, J Goto, MT Lotze, JK Kolls, H Sasaki	Journal of immunology (Baltimore, Md. : 1950)	2005
CXC chemokines in angiogenesis RM Strieter, MD Burdick, BN Gomperts, JA Belperio, MP Keane	Cytokine & Growth Factor Reviews	2005
The Role of CXCR2/CXCR2 Ligand Biological Axis in Renal Cell Carcinoma J Mestas, MD Burdick, K Reckamp, A Pantuck, RA Figlin, RM Strieter	Journal of immunology (Baltimore, Md. : 1950)	2005
Chemokines and Their Receptors: Roles in Specific Clinical Conditions and Measurement in the Clinical Laboratory M Locati, R Bonecchi, MM Corsi	Pathology Patterns Reviews	2005
K-ras activation generates an inflammatory response in lung tumors H Ji, AM Houghton, TJ Mariani, S Perera, CB Kim, R Padera, G Tonon, K McNamara, LA Marconcini, A Hezel, N El-Bardeesy, RT Bronson, D Sugarbaker, RS Maser, SD Shapiro, KK Wong	Oncogene	2005
Pathophysiology of tumor neovascularization M Furuya, M Nishiyama, Y Kasuya, S Kimura, H Ishikura	Vascular Health and Risk Management	2005
PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer VG Keshamouni, DA Arenberg, RC Reddy, MJ Newstead, S Anthwal, TJ Standiford	Neoplasia (New York, N.Y.)	2005
Up-regulation of the interferon γ (IFN-γ)-inducible chemokines IFN-inducible T-cell α chemoattractant and monokine induced by IFN-γ and of their receptor CXC receptor 3 in human renal cell carcinoma T Suyama, M Furuya, M Nishiyama, Y Kasuya, S Kimura, T Ichikawa, T Ueda, T Nikaido, H Ito, H Ishikura	Cancer	2005
Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells H Takahashi, M Numasaki, MT Lotze, H Sasaki	Immunology Letters	2005
PPAR-γ Activation Inhibits Angiogenesis by Blocking ELR+CXC Chemokine Production in Non-small Cell Lung Cancer VG Keshamouni, DA Arenberg, RC Reddy, MJ Newstead, S Anthwal, TJ Standiford	Neoplasia (New York, N.Y.)	2005
Delivery of Systemic Chemotherapeutic Agent to Tumors by Using Focused Ultrasound: Study in a Murine Model1 EL Yuh, SG Shulman, SA Mehta, J Xie, L Chen, V Frenkel, MD Bednarski, KC Li	Radiology	2005
Role of IL-6 in systemic angiogenesis of the lung JY McClintock, EM Wagner	Journal of applied physiology	2005
Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer M Põld, LX Zhu, S Sharma, MD Burdick, Y Lin, PP Lee, A Põld, J Luo, K Krysan, M Dohadwala, JT Mao, RK Batra, RM Strieter, SM Dubinett	Cancer research	2004
CXC chemokines: the regulatory link between inflammation and angiogenesis P Romagnani, L Lasagni, F Annunziato, M Serio, S Romagnani	Trends in Immunology	2004
CXC chemokines in angiogenesis of cancer RM Strieter, JA Belperio, RJ Phillips, MP Keane	Seminars in Cancer Biology	2004
Cancer immunotherapy with chemoattractant peptides M Coscia, A Biragyn	Seminars in Cancer Biology	2004
Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis CL Addison, JA Belperio, MD Burdick, RM Strieter	BMC Cancer	2004
Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer J Petroziello, A Yamane, L Westendorf, M Thompson, C McDonagh, C Cerveny, CL Law, A Wahl, P Carter	Oncogene	2004
Vascular remodeling in the circulations of the lung W Mitzner, EM Wagner	Journal of applied physiology	2004
Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities AK Bauer, AM Malkinson, SR Kleeberger	American journal of physiology. Lung cellular and molecular physiology	2004
Cancer and Inflammation DW Morgan, UJ Forssmann, MT Nakada		2004
Growth Factors and their Receptors in Cancer Metastasis CR Snyder, WG Jiang, K Matsumoto, T Nakamura		2004
Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer MP Keane, JA Belperio, YY Xue, MD Burdick, RM Strieter	Journal of immunology (Baltimore, Md. : 1950)	2004
Specific Keynote: Molecular Determinants of Angiogenesis in Ovarian Cancer IJ Fidler, J Yoneda, C Herrera, J Wood, L Xu	Gynecologic Oncology	2003
Tumor angiogenesis of non-small cell lung cancer N Shijubo, H Kojima, M Nagata, T Ohchi, A Suzuki, S Abe, N Sato	Microscopy Research and Technique	2003
Chemokine biology in cancer F Balkwill	Seminars in Immunology	2003
Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities PE van Steen, A Wuyts, SJ Husson, P Proost, JV Damme, G Opdenakker	European Journal of Biochemistry	2003
Lung Biology in Health and Disease N Zamel	Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential	2003
Chemokines in the Lung W Tsai, B Mehrad	Chemokines in the Lung	2003
Biopsy Neutrophilia, Neutrophil Chemokine and Receptor Gene Expression in Severe Exacerbations of Chronic Obstructive Pulmonary Disease Y Qiu, J Zhu, V Bandi, RL Atmar, K Hattotuwa, KK Guntupalli, PK Jeffery	American journal of respiratory and critical care medicine	2003
The CXC Chemokine GCP-2/CXCL6 Is Predominantly Induced in Mesenchymal Cells by Interleukin-1β and Is Down-Regulated by Interferon-γ: Comparison with Interleukin-8/CXCL8 A Wuyts, S Struyf, K Gijsbers, E Schutyser, W Put, R Conings, JP Lenaerts, K Geboes, G Opdenakker, P Menten, P Proost, JV Damme	Laboratory Investigation	2003
Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma ES Doubrovina, MM Doubrovin, E Vider, RB Sisson, RJ OReilly, B Dupont, YM Vyas	Journal of immunology (Baltimore, Md. : 1950)	2003
CHEMOKINES: AGENTS FOR THE IMMUNOTHERAPY OF CANCER? B Homey, A Müller, A Zlotnik	Nature Reviews Immunology	2002
Universes in Delicate Balance RH Miller, S Robinson	Universes in Delicate Balance	2002
Gene Therapy in Lung Disease K Amin	Gene Therapy in Lung Disease	2002
The role of cytokines in the epithelial cancer microenvironment J Wilson, F Balkwill	Seminars in Cancer Biology	2002
Autocrine production of epithelial cell–derived neutrophil attractant-78 induced by granulocyte colony-stimulating factor in neutrophils S Suzuki, M Kobayashi, K Chiba, I Horiuchi, J Wang, T Kondoh, S Hashino, J Tanaka, M Hosokawa, M Asaka	Blood	2002
Monocyte-Fibronectin Interactions, Via α 5 β 1 Integrin, Induce Expression of CXC Chemokine-Dependent Angiogenic Activity ES White, DL Livant, S Markwart, DA Arenberg	Journal of immunology (Baltimore, Md. : 1950)	2001
The Cytokine FactsBook and Webfacts KA Fitzgerald, LA O'Neill, AJ Gearing, RE Callard	The Cytokine FactsBook and Webfacts	2001
ENA-78 Is an Important Angiogenic Factor in Idiopathic Pulmonary Fibrosis MP Keane, JA Belperio, MD Burdick, JP Lynch, MC Fishbein, RM Strieter	American journal of respiratory and critical care medicine	2001
The Role of CXC Chemokines in the Regulation of Tumor Angiogenesis S Dias, M Choy, S Rafii	Cancer Investigation	2001
Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis K Kozaki, K Koshikawa, Y Tatematsu, O Miyaishi, H Saito, T Hida, H Osada, T Takahashi	Oncogene	2001
Non-Small Cell Lung Cancer Cells Induce Monocytes to Increase Expression of Angiogenic Activity ES White, SR Strom, NL Wys, DA Arenberg	Journal of immunology (Baltimore, Md. : 1950)	2001
Overexpression of CXC Chemokines by an Adrenocortical Carcinoma: A Novel Clinical Syndrome DE Schteingart, TJ Giordano, RS Benitez, MD Burdick, MN Starkman, DA Arenberg, RM Strieter	The Journal of clinical endocrinology and metabolism	2001
The CXC Chemokine, Monokine Induced by Interferon-gamma, Inhibits Non-Small Cell Lung Carcinoma Tumor Growth and Metastasis CL Addison, DA Arenberg, SB Morris, YY Xue, MD Burdick, MS Mulligan, MD Iannettoni, RM Strieter	Human Gene Therapy	2000
Chemokines, Chemokine Receptors, and Renal Disease: From Basic Science To Pathophysiologic and Therapeutic Studies S Segerer, PJ Nelson, D Schlöndorff	Journal of the American Society of Nephrology : JASN	2000
The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR + CXC Chemokine-Induced Angiogenic Activity CL Addison, TO Daniel, MD Burdick, H Liu, JE Ehlert, YY Xue, L Buechi, A Walz, A Richmond, RM Strieter	Journal of immunology (Baltimore, Md. : 1950)	2000
Distinct CXC Chemokines Mediate Tumorigenicity of Prostate Cancer Cells BB Moore, DA Arenberg, K Stoy, T Morgan, CL Addison, SB Morris, M Glass, C Wilke, YY Xue, S Sitterding, SL Kunkel, MD Burdick, RM Strieter	The American Journal of Pathology	1999
Molecular pathogenesis of lung cancer KM Fong, Y Sekido, JD Minna	The Journal of Thoracic and Cardiovascular Surgery	1999
Autocrine loops, signal transduction, and cell cycle abnormalities in the molecular biology of lung cancer E Rozengurt	Current Opinion in Oncology	1999
Myofibroblasts. I. Paracrine cells important in health and disease D Li, SL Friedman	The American journal of physiology	1999
Use of Immunodeficient Mice for the Evaluation of CXC Chemokines in the Regulation of Tumor-associated Angiogenesis RM Strieter, CL Addison, JE Ehlert, MP Keane, JA Belperio, MD Burdick, DA Arenberg	ILAR journal / National Research Council, Institute of Laboratory Animal Resources	1999
Chemokine receptor expression by human intestinal epithelial cells M B Dwinell, L Eckmann, J D Leopard, N M Varki, M F Kagnoff	Gastroenterology	1999
Antiangiogenic and antitumor effects of 14-membered ring macrolides on mouse B16 melanoma cells J Yatsunami, Y Fukuno, M Nagata, M Tominaga, S Aoki, N Tsuruta, M Kawashima, S Taniguchi, S Hayashi	Clinical & Experimental Metastasis	1999
Advances in Pharmacology B Drenger, Y Ginosar, Y Gozal	Advances in Pharmacology	1994
Differences in the peritoneal response to pristane in BALB/cAnPt and BALB/cJ mice LM Coussens, Z Werb	Current topics in microbiology and immunology	1985
Differences in the peritoneal response to pristane in BALB/cAnPt and BALB/cJ mice LM Coussens, Z Werb	Current topics in microbiology and immunology	1985

Advertisement